Investors are bracing for a report on the consumer price index for January, a key input for Fed policy making on rates.

Investors are bracing for a report on the consumer price index for January, a key input for Fed policy making on rates.

Investors are bracing for a report on the consumer price index for January, a key input for Fed policy making on rates.

Odds of a Fed rate cut in June nudge higher after 'core' consumer inflation comes in at its lowest rate in four years.

Odds of a Fed rate cut in June nudge higher after 'core' consumer inflation comes in at its lowest rate in four years.

Odds of a Fed rate cut in June nudge higher after 'core' consumer inflation comes in at its lowest rate in four years.

Shares of Apple dropped 5% Thursday, in the stock's worst day since April after a string of bad news.

A number of stocks fell in the afternoon session after investors continued to distinguish between the winners and losers in the artificial intelligence boom, leading to a broad sell-off.

A number of stocks fell in the afternoon session after investors continued to distinguish between the winners and losers in the artificial intelligence boom, leading to a broad sell-off.

A number of stocks fell in the afternoon session after investors continued to distinguish between the winners and losers in the artificial intelligence boom, leading to a broad sell-off.

Online grocery delivery platform Instacart (NASDAQ:CART) announced better-than-expected revenue in Q4 CY2025, with sales up 12.3% year on year to $992 million. Its GAAP profit of $0.30 per share was 41.3% below analysts’ consensus estimates.

Palantir shares tumbled Thursday, extending their recent slide as the data analytics software provider's stock gained another bearish call from high-profile investor.

Online accommodations platform Airbnb (NASDAQ:ABNB) announced better-than-expected revenue in Q4 CY2025, with sales up 12% year on year to $2.78 billion. Guidance for next quarter’s revenue was optimistic at $2.61 billion at the midpoint, 3% above analyst

Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 13.8% year on year to $44.65 million. Its non-GAAP loss of $0.12 per share was 10.8% above analysts’ conse

Biotech company 10x Genomics (NASDAQ:TXG) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales were flat year on year at $166 million. The company expects the full year’s revenue to be around $612.5 million, close to analysts’ esti